Andrew Newman

Andrew Newman is a Laboratory Validation Specialist at ConvaTec since January 2022, with extensive experience in analytical and development roles across the pharmaceutical industry. Prior to this position, Andrew served as the Analytical Team Leader at H&T Presspart, focusing on inhalation product technology from June 2017 to January 2022. Andrew's career includes significant contributions as a Senior Development Scientist at Pharmaserve North West, where projects involved inhaled treatments and nicotine delivery systems. Earlier roles include Quality Officer and Scientist 3 at Vectura, where responsibilities spanned quality control, quality assurance, and respiratory product development. Andrew's experience also encompasses analytical services and scientific officer roles at Catalent Pharma Solutions and Patheon UK Ltd, as well as foundational work as a QC Analyst at Pharmasol and Analyst at Rugby Cement. Andrew holds a BSc (Hons) in Biochemistry & Biomedical Physics from the University of Nottingham.